Literature DB >> 11692158

Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.

S Hoffmann1, T Krause, P P van Geel, R Willenbrock, I Pagel, Y M Pinto, H Buikema, W H van Gilst, C Lindschau, M Paul, T Inagami, D Ganten, H Urata.   

Abstract

Angiotensin II is known to stimulate cardiac hypertrophy and contractility. Most angiotensin II effects are mediated via membrane bound AT1 receptors. However, the role of myocardial AT1 receptors in cardiac hypertrophy and contractility is still rarely defined. To address the hypothesis that increased myocardial AT1 receptor density causes cardiac hypertrophy apart from high blood pressure we developed a transgenic rat model which expresses the human AT1 receptor under the control of the alpha-myosin heavy-chain promoter specifically in the myocardium. Expression was identified and quantified by northern blot analysis and radioligand binding assays, demonstrating overexpression of angiotensin II receptors in the transgenic rats up to 46 times the amount seen in nontransgenic rats. Coupling of the human AT1 receptor to rat G proteins and signal transduction cascade was verified by sensitivity to GTP-gamma-S and increased sensitivity of intracellular Ca2+ [Ca2+]i to angiotensin II in fluo-3 loaded transgenic cardiomyocytes. Transgenic rats exhibited normal cardiac growth and function under baseline conditions. Pronounced hypertrophic growth and contractile responses to angiotensin II, however, were noted in transgenic rats challenged by volume and pressure overload. In summary, we generated a new transgenic rat model that exhibits an upregulated myocardial AT1 receptor density and demonstrates augmented cardiac hypertrophy and contractile response to angiotensin II after volume and pressure overload, but not under baseline conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692158     DOI: 10.1007/s001090100246

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  8 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.

Authors:  Suresh Kumar Verma; Prasanna Krishnamurthy; David Barefield; Neha Singh; Rajesh Gupta; Erin Lambers; Melissa Thal; Alexander Mackie; Eneda Hoxha; Veronica Ramirez; Gangjian Qin; Sakthivel Sadayappan; Asish K Ghosh; Raj Kishore
Journal:  Circulation       Date:  2012-06-15       Impact factor: 29.690

3.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 4.  Update on tissue renin-angiotensin systems.

Authors:  Michael Bader; Detlev Ganten
Journal:  J Mol Med (Berl)       Date:  2008-04-15       Impact factor: 4.599

5.  Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice.

Authors:  M G Pereira; J C B Ferreira; C R Bueno; K C Mattos; K T Rosa; M C Irigoyen; E M Oliveira; J E Krieger; Patricia Chakur Brum
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

6.  Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.

Authors:  Hsiang-Hao Hsu; Sigrid Hoffmann; Nicole Endlich; Ana Velic; Albrecht Schwab; Thomas Weide; Eberhard Schlatter; Hermann Pavenstädt
Journal:  J Mol Med (Berl)       Date:  2008-09-05       Impact factor: 4.599

7.  Functional characterization of the human atrial essential myosin light chain (hALC-1) in a transgenic rat model.

Authors:  Ahmed Ihab Abdelaziz; Jadranka Segaric; Holger Bartsch; Daria Petzhold; Wolfgang-Peter Schlegel; Monika Kott; Ingo Seefeldt; Joachim Klose; Michael Bader; Hannelore Haase; Ingo Morano
Journal:  J Mol Med (Berl)       Date:  2004-02-24       Impact factor: 4.599

Review 8.  Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system.

Authors:  Frans H H Leenen; Mordecai P Blaustein; John M Hamlyn
Journal:  Endocr Connect       Date:  2017-08-30       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.